145 related articles for article (PubMed ID: 32845913)
1. Tumor-infiltrating CD62L+PD-1-CD8 T cells retain proliferative potential via Bcl6 expression and replenish effector T cells within the tumor.
Gong Y; Suzuki T; Kozono H; Kubo M; Nakano N
PLoS One; 2020; 15(8):e0237646. PubMed ID: 32845913
[TBL] [Abstract][Full Text] [Related]
2. Functional properties and lineage relationship of CD8+ T cell subsets identified by expression of IL-7 receptor alpha and CD62L.
Bachmann MF; Wolint P; Schwarz K; Jäger P; Oxenius A
J Immunol; 2005 Oct; 175(7):4686-96. PubMed ID: 16177116
[TBL] [Abstract][Full Text] [Related]
3. Bcl6 is essential for the generation of long-term memory CD4+ T cells.
Ichii H; Sakamoto A; Arima M; Hatano M; Kuroda Y; Tokuhisa T
Int Immunol; 2007 Apr; 19(4):427-33. PubMed ID: 17307796
[TBL] [Abstract][Full Text] [Related]
4. Understanding the biology of ex vivo-expanded CD8 T cells for adoptive cell therapy: role of CD62L.
Díaz-Montero CM; Zidan AA; Pallin MF; Anagnostopoulos V; Salem ML; Wieder E; Komanduri K; Montero AJ; Lichtenheld MG
Immunol Res; 2013 Dec; 57(1-3):23-33. PubMed ID: 24218360
[TBL] [Abstract][Full Text] [Related]
5. Bcl6 acts as an amplifier for the generation and proliferative capacity of central memory CD8+ T cells.
Ichii H; Sakamoto A; Kuroda Y; Tokuhisa T
J Immunol; 2004 Jul; 173(2):883-91. PubMed ID: 15240675
[TBL] [Abstract][Full Text] [Related]
6. Functionally heterogeneous CD8(+) T-cell memory is induced by Sendai virus infection of mice.
Usherwood EJ; Hogan RJ; Crowther G; Surman SL; Hogg TL; Altman JD; Woodland DL
J Virol; 1999 Sep; 73(9):7278-86. PubMed ID: 10438816
[TBL] [Abstract][Full Text] [Related]
7. L-Selectin Enhanced T Cells Improve the Efficacy of Cancer Immunotherapy.
Watson HA; Durairaj RRP; Ohme J; Alatsatianos M; Almutairi H; Mohammed RN; Vigar M; Reed SG; Paisey SJ; Marshall C; Gallimore A; Ager A
Front Immunol; 2019; 10():1321. PubMed ID: 31249570
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of central memory CD8 T cells is independent of CD62L-mediated trafficking to lymph nodes.
Wirth TC; Badovinac VP; Zhao L; Dailey MO; Harty JT
J Immunol; 2009 May; 182(10):6195-206. PubMed ID: 19414773
[TBL] [Abstract][Full Text] [Related]
9. HDAC9 deficiency promotes tumor progression by decreasing the CD8
Ning Y; Ding J; Sun X; Xie Y; Su M; Ma C; Pan J; Chen J; Jiang H; Qi C
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32554611
[TBL] [Abstract][Full Text] [Related]
10. Marked anti-tumor effects of CD8(+)CD62L(+) T cells from melanoma-bearing mice.
Liao Y; Geng P; Tian Y; Miao H; Liang H; Zeng R; Ni B; Ruan Z
Immunol Invest; 2015; 44(2):147-63. PubMed ID: 25122543
[TBL] [Abstract][Full Text] [Related]
11. Development of tumor-infiltrating CD8+ T cell memory precursor effector cells and antimelanoma memory responses are the result of vaccination and TGF-β blockade during the perioperative period of tumor resection.
Bellavance EC; Kohlhapp FJ; Zloza A; O'Sullivan JA; McCracken J; Jagoda MC; Lacek AT; Posner MC; Guevara-Patino JA
J Immunol; 2011 Mar; 186(6):3309-16. PubMed ID: 21289306
[TBL] [Abstract][Full Text] [Related]
12. Location rather than CD62L phenotype is critical in the early establishment of influenza-specific CD8+ T cell memory.
Kedzierska K; Stambas J; Jenkins MR; Keating R; Turner SJ; Doherty PC
Proc Natl Acad Sci U S A; 2007 Jun; 104(23):9782-7. PubMed ID: 17522251
[TBL] [Abstract][Full Text] [Related]
13. Adoptive immunotherapy of advanced tumors with CD62 L-selectin(low) tumor-sensitized T lymphocytes following ex vivo hyperexpansion.
Wang LX; Chen BG; Plautz GE
J Immunol; 2002 Sep; 169(6):3314-20. PubMed ID: 12218152
[TBL] [Abstract][Full Text] [Related]
14. Both regulatory T cells and antitumor effector T cells are primed in the same draining lymph nodes during tumor progression.
Hiura T; Kagamu H; Miura S; Ishida A; Tanaka H; Tanaka J; Gejyo F; Yoshizawa H
J Immunol; 2005 Oct; 175(8):5058-66. PubMed ID: 16210609
[TBL] [Abstract][Full Text] [Related]
15. Cutting Edge: Transcription Factor BCL6 Is Required for the Generation, but Not Maintenance, of Memory CD8
Liu Z; Guo Y; Tang S; Zhou L; Huang C; Cao Y; Huang H; Wu X; Meng D; Ye L; He H; Xie Z; Wu Y; Liu X; Zhou X
J Immunol; 2019 Jul; 203(2):323-327. PubMed ID: 31175159
[TBL] [Abstract][Full Text] [Related]
16. The shedding of CD62L (L-selectin) regulates the acquisition of lytic activity in human tumor reactive T lymphocytes.
Yang S; Liu F; Wang QJ; Rosenberg SA; Morgan RA
PLoS One; 2011; 6(7):e22560. PubMed ID: 21829468
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous assessment of antigen-stimulated cytokine production and memory subset composition of memory CD8 T cells.
Jabbari A; Harty JT
J Immunol Methods; 2006 Jun; 313(1-2):161-8. PubMed ID: 16762359
[TBL] [Abstract][Full Text] [Related]
18. CD8
Mellouk A; Bobé P
FASEB J; 2019 Mar; 33(3):3225-3236. PubMed ID: 30383448
[TBL] [Abstract][Full Text] [Related]
19. CD4+CD25+Foxp3+ regulatory T cells are dispensable for controlling CD8+ T cell-mediated lung inflammation.
Tosiek MJ; Gruber AD; Bader SR; Mauel S; Hoymann HG; Prettin S; Tschernig T; Buer J; Gereke M; Bruder D
J Immunol; 2011 Jun; 186(11):6106-18. PubMed ID: 21518973
[TBL] [Abstract][Full Text] [Related]
20. L-selectin-negative CCR7- effector and memory CD8+ T cells enter reactive lymph nodes and kill dendritic cells.
Guarda G; Hons M; Soriano SF; Huang AY; Polley R; Martín-Fontecha A; Stein JV; Germain RN; Lanzavecchia A; Sallusto F
Nat Immunol; 2007 Jul; 8(7):743-52. PubMed ID: 17529983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
